What You Should Know:
- CVS Health Clinical Trial Services and late clinical-stage cellular therapeutics company ProKidney Corp. today announced a collaboration to enroll patients with type 2 diabetes and chronic kidney disease into the proact 1 (REGEN-006) Phase 3 clinical trial of REACT®.
ProKidney’s lead product candidate, REACT® (REnal Autologous Cell Therapy), is a first-of-its-kind, patented, autologous cellular therapy with the potential to not only slow and stabilize the
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Curebase Launches Remote First DTx Research Platform
What You Should Know:
- Curebase, a company committed to democratizing access to clinical trials, announced the release of its integrated software and services package for digital therapeutics (DTx) trials that accelerates enrollment and allows sponsors to launch their studies faster.
- Available now, the new Curebase offering includes the first one-stop-shop decentralized clinical trial (DCT) platform bundled with site and trial execution services for the DTx market.
Making
Read More
Healthcare AI Transformation: 9 Executive Predictions to Watch in 2023
Piotr Orzechowski, Co-Founder and CEO of Infermedica
Innovation areas to watch: One of the exciting areas of applied machine learning recently is so-called Generative Tech. Some say it’s the biggest change to the Internet since crypto was invented. Generative Tech is developing at an unprecedented pace and many of us already had a chance to enjoy images created by OpenAI’s DALLE-E or content generated by GPT-3 language model. However real-world applications of generative tech in health are
Read More
Boosting Clinical Trial Recruitment Requires Humanity – and Technology
Clinical trials should be a time of promise for better patient outcomes, as they explore new ways to potentially help patients suffering from a variety of conditions. Instead, this phase of treatment development is often met with exasperation as patients, researchers, and drug developers deal with the many barriers to clinical trial recruitment and access.
There are two central – and intrinsically linked – problems with the current state of clinical trial recruitment in the U.S.:
Read More
Exec Hires: Greenphire Appoints Owen Newman as the CFO
What You Should Know:
- Greenphire, the global leader in financial lifecycle management for clinical trials, today announced the appointment of Owen Newman as the Chief Financial Officer (CFO).
- Newman brings more than 25 years of financial experience, most recently as CFO of Simeio, a global leader in Identity and Access Management. Newman will report directly to Greenphire's CEO, Jim Murphy.
Owen Newman Bio/Background
Newman is a mature business leader experienced at leading
Read More
7 Life Sciences Executive Predictions to Watch in 2023
Tracy Curley, CFO and interim CEO at iSpecimen
Focusing on the macroeconomic environment, which remains impacted by the lingering COVID-19 pandemic, there continues to be uncertainty about the strength of the global, Asia Pacific, UK and US economies. High-interest rates and a potential recession remain a concern for all market participants. At ISPC, we are closely monitoring the pace of specimen transactions. We believe that this industry can be resilient through a continued economic
Read More
20 Executives Share Health IT Predictions to Watch in 2023
We asked several healthcare executives to share their health IT predictions and trends for 2023.
Nate Maslak, the co-founder/CEO of Ribbon Health
Data Personalization: 38% of consumers want more personalized and inclusive healthcare options. In 2023, we’ll see a greater shift towards healthcare enterprises prioritizing this personalization, by innovating their current data infrastructure to show a range of information that lets a patient make an educated care decision based on what
Read More
Real-World Data Startup Crescendo Health Launches with $3.2M
What You Should Know:
- Crescendo Health, a real-world data startup that's drastically reshaping how clinical researchers get access to hard-to-reach patient data to support their clinical research today officially announced its launch with $3.4M in seed funding from Define Ventures as well as the founders and CEOs of many other well-known organizations.
- Founded by the co-founder of Datavant (merged with Ciox in a $7 billion deal), and a top product-management leader from Grand
Read More
Withings Unveils Mini At-Home Urine Analysis Platform for Clinical Trials & RPM
What You Should Know:
- During a press preview event at CES last night, Withings unveiled, U-Scan, a miniaturized urine health lab that will change the way people and health professionals will monitor vitals from the comfort and privacy of their own bathroom.
- U-Scan consists of a technologically advanced pebble-shaped urine analysis reader that sits within the toilet bowl. Its changeable cartridges are designed to assess specific biomarkers without the need for
Read More
Pangea Biomed Adds $5M for its Multi-Cancer Response Predictor
What You Should Know:
- Pangea Biomed, the biotech company behind ENLIGHT, the multi-cancer response predictor improving the effectiveness of precision oncology, announced $5M in additional funding reaching a total seed round of $12M.
- The latest fundraising is led by angel investor Danny Tocatly and existing investor NFX, and will be used to expand US operations, drive commercial partnerships, and scale product offerings.
Expanding US Operations and Fostering Commercial
Read More
